Pricing is the most frequently benchmarked metric in medspa operations, yet the most opaque. Unlike pharmaceutical costs (which are published) or device acquisition (which is negotiated), treatment fees vary wildly by geography, provider credential, patient demographic, and brand loyalty. A Botox unit in Manhattan commands 2–3× the fee of the same unit in a secondary market; a syringe of Juvederm Ultra Plus might be $550 in a high-income suburb and $350 in a mid-market city. For practice owners, the stakes are clear: underprice and you leave margin on the table and signal lower quality; overprice and you lose volume to competitors. This page aggregates the structural drivers of pricing variation and provides a framework for validating your own fees against regional benchmarks—without relying on anecdotal data from competitors or outdated industry surveys.